IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q3 2013 Holdings

Filed 2013-11-15 | 11 holdings | $187.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Medivation, Inc.Com58501N101$148.9K2,484,10179.5%
Ampio Pharmaceuticals Inc.Com03209T109$15.2K2,026,9988.1%
Alcobra LtdSHSM2239P109$10.6K587,0005.7%
Vivus Inc.Com928551100$4.7K500,0002.5%
Genworth Finl Inc(GNW)Com CL A37247D106$2.7K211,0001.4%
Sequenom Inc.Com New817337405$2.4K893,6001.3%
Newlink Genetics CorpCom651511107$1.5K77,4370.8%
Keryx Biopharmaceuticals Inc.Com492515101$1.0K100,0000.5%
Celgene Corp(CELG)Com151020104$22527,9250.1%
Exact Sciences Corp(EXAS)Com30063P105$16514,0000.1%
Echo Therapeutics Inc.Com New27876L206$12344,4450.1%